Publicações

An International Phase 3 Randomized, Placebo-Controlled Study of Cc-486 (Oral Azacitidine) Maintenance Therapy in Patients with Acute Myeloid Leukemia (Aml) in Complete Remission (Cr): The Quazar Aml Maintenance Trial.

AuthID
P-00G-EW5

Author(s)

Roboz, GJ

Ravandi, F

Selleslag, D

Montesinos, P

Wei, A

Porkka, K

Almeida, A

Savona, MR

Mohan, SR

Falantes, JF

Voso, MT

Kumar, K

Camus, F

La Torre, I

Kantarjian, H

Skikne, B

Tipo de Documento

Abstract

Year published

2015

Publicado

in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X

Volume: 33, Número: 15

Conference

Annual Meeting of the American-Society-Of-Clinical-Oncology (Asco), Date: MAY 29-JUN 02, 2015, Location: Chicago, IL, Patrocinadores: Amer Soc Clin Oncol

Indexing

Wos^®

Metadata
Fontes

Publication Identifiers

Wos: WOS:000358036904840

Source Identifiers

ISSN: 0732-183X

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

An International Phase 3 Randomized, Placebo-Controlled Study of Cc-486 (Oral Azacitidine) Maintenance Therapy in Patients with Acute Myeloid Leukemia (Aml) in Complete Remission (Cr): The Quazar Aml Maintenance Trial.

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

An International Phase 3 Randomized, Placebo-Controlled Study of Cc-486 (Oral Azacitidine) Maintenance Therapy in Patients with Acute Myeloid Leukemia (Aml) in Complete Remission (Cr): The Quazar Aml Maintenance Trial.

Links Úteis

Ajuda